Professor Mark H. Wilcox, MD, FRCPath

Professor of Medical Microbiology
University of Leeds; Leeds Teaching Hospitals NHS Trust, United Kingdom

Disclosure(s): GSK: Advisor/Consultant, Board Member, Grant/Research Support; Pfizer: Advisor/Consultant; Phico Therapeutics: Board Member; Seres: Advisor/Consultant, Board Member, Grant/Research Support; Summit: Advisor/Consultant, Grant/Research Support

Poster(s):

• 221 - Assessment and Proposed Revision of Clinical Trial Clostridioides difficile Infection Clinical Response and Outcomes Definitions
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET